RP5063

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
RP5063 in Subjects With Schizophrenia or Schizoaffective DisorderNCT01490086Reviva PharmaceuticalsPhase 2Completed2013-03Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.